Augma Biomaterials 3.15

The activity of the company is based on two main aspects:
* Development of novel augmentative products that are based
on many years of personal experience and consider the challenges, which clinicians in the dental field face.

* Service and broad support for clinicians to ensure better, faster and readily achievable results for the dental surgeons.

The idea of forming the company was born from the need of the developer, Dr.Yahav Amos, D.M.D, to find a bone graft substitute that could serve clinicians in a wider spectrum of indications, based on motivation to find the ultimate one.